Cladribine as monotherapy or combined with dexamethasone and idarubicin ormitoxantrone in previously treated patients with low-grade lymphoid malignancies

Authors
Robak, T Gora-Tybor, J Chojnowski, K
Citation
T. Robak et al., Cladribine as monotherapy or combined with dexamethasone and idarubicin ormitoxantrone in previously treated patients with low-grade lymphoid malignancies, HAEMATOLOG, 85(2), 2000, pp. 215-216
Citations number
10
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
HAEMATOLOGICA
ISSN journal
03906078 → ACNP
Volume
85
Issue
2
Year of publication
2000
Pages
215 - 216
Database
ISI
SICI code
0390-6078(200002)85:2<215:CAMOCW>2.0.ZU;2-3
Abstract
We compared efficiency and toxicity of cladribine (2-CdA) in monotherapy an d in combination with dexamethasone and mitoxantrone (CMD) or idarubicin (C ID) in pretreated patients with low grade NHL. We have shown that 2-CdA has significant activity in this disease but the addition of dexamethasone and anthracycIines may not be of advantage compared to 2-CdA alone.